Molecular docking and experimental evaluation of neocuproine in targeting in vitro model of Parkinson’s disease caused by 6-hydroxydopamine

Background 6-Hydroxydopamine (6-OHDA) induces oxidative and cellular stress in SH-SY5Y cells and is widely used as an in vitro model relevant to Parkinson’s disease (PD). This study investigated the effects of neocuproine, a copper chelator, on 6-OHDA-induced cellular injury in SH-SY5Y cells. Results 6-OHDA increased total oxidant status (TOS), malondialdehyde (MDA), caspase-3 (CASP3), LDH release, and IL-1β and TNF-α levels, while reducing cell viability and total antioxidant capacity (TAC). Neocuproine treatment reduced LDH, TOS, MDA, CASP3, IL-1β, and TNF-α levels and increased TAC compared with the 6-OHDA group. The response was non-linear, with several effects being more pronounced at intermediate concentrations. Neocuproine also reduced α-synuclein immunofluorescence and increased TH immunofluorescence at selected concentrations. Molecular docking provided exploratory information on the predicted interactions of neocuproine with selected PD-related proteins. Conclusion Neocuproine was associated with reduced oxidative stress, cellular injury, and inflammatory marker levels in the 6-OHDA-induced SH-SY5Y model. These findings support further investigation of neocuproine in experimental PD models. However, the absence of a standard comparator and complementary protein-level validation limits conclusions regarding its mechanism and therapeutic applicability.

Authors

Institutions

Publication Details

Journal
BMC Neuroscience
Published
2026-11-21
DOI
https://doi.org/10.1186/s12868-026-01070-x
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Molecular docking and experimental evaluation of neocuproine in targeting in vitro model of Parkinson’s disease caused by 6-hydroxydopamine

Ali Sefa Mendĭl, Güven Akçay, Fatma Yeşilyurt, Mustafa Özkaraca et al.
BMC Neuroscience
Parkinson's Disease Mechanisms and Treatments
article

Molecular docking and experimental evaluation of neocuproine in targeting in vitro model of Parkinson’s disease caused by 6-hydroxydopamine

Ali Sefa Mendĭl, Güven Akçay, Fatma Yeşilyurt, Mustafa Özkaraca, Dilara Nemutlu Samur, Ahmet Hacımüftüoğlu, Selma Yaman
article en

Abstract

Background 6-Hydroxydopamine (6-OHDA) induces oxidative and cellular stress in SH-SY5Y cells and is widely used as an in vitro model relevant to Parkinson’s disease (PD). This study investigated the effects of neocuproine, a copper chelator, on 6-OHDA-induced cellular injury in SH-SY5Y cells. Results 6-OHDA increased total oxidant status (TOS), malondialdehyde (MDA), caspase-3 (CASP3), LDH release, and IL-1β and TNF-α levels, while reducing cell viability and total antioxidant capacity (TAC). Neocuproine treatment reduced LDH, TOS, MDA, CASP3, IL-1β, and TNF-α levels and increased TAC compared with the 6-OHDA group. The response was non-linear, with several effects being more pronounced at intermediate concentrations. Neocuproine also reduced α-synuclein immunofluorescence and increased TH immunofluorescence at selected concentrations. Molecular docking provided exploratory information on the predicted interactions of neocuproine with selected PD-related proteins. Conclusion Neocuproine was associated with reduced oxidative stress, cellular injury, and inflammatory marker levels in the 6-OHDA-induced SH-SY5Y model. These findings support further investigation of neocuproine in experimental PD models. However, the absence of a standard comparator and complementary protein-level validation limits conclusions regarding its mechanism and therapeutic applicability.

BMC Neuroscience
Sivas Cumhuriyet Üniversitesi (TR), Kahramanmaraş Sütçü İmam University (TR), Atatürk University (TR), Bolu Abant İzzet Baysal University (TR), Erciyes University (TR)
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon